Autoimmune hypoglycemia expands the biological spectrum of HHV8(+) multicentric Castleman disease

Autoimmune hypoglycemia belongs to the clinical spectrum of HHV8(+) MCD and rituximab is an effective treatment of this condition. This rare complication is related to autoantibodies directed toward the insulin receptor and activating the insulin signaling pathway.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Arnautou, Pierre, Auclair, Martine, Fellahi, Soraya, Bouché, Clara, Fieschi, Claire, Barrak, Elias, Queyrel-Moranne, Viviane, Chaillous, Lucy, Blin, Nicolas, Malphettes, Marion, Fadlallah, Jehane, Bertinchamp, Remi, Gérard, Laurence, Bengoufa, Djaouida, Galicier, Lionel, Oksenhendler, Eric, Vigouroux, Corinne, Boutboul, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2021
Assuntos:
Stimulus Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045508/
https://ncbi.nlm.nih.gov/pubmed/33787862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002801
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados